These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32308772)

  • 1. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
    Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
    López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
    Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
    Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Lakatosh SA; Barcia J; Guzmán M; Velasco G
    Cell Death Differ; 2011 Jun; 18(6):959-73. PubMed ID: 21233844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
    Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
    Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.
    Kawauchi D; Takahashi M; Satomi K; Yamamuro S; Kobayashi T; Uchida E; Honda-Kitahara M; Narita Y; Iwadate Y; Ichimura K; Tomiyama A
    Cancer Sci; 2021 Jun; 112(6):2442-2453. PubMed ID: 33728771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
    Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
    Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
    Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
    J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
    Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
    Wang H; Sun T; Hu J; Zhang R; Rao Y; Wang S; Chen R; McLendon RE; Friedman AH; Keir ST; Bigner DD; Li QJ; Wang H; Wang XF
    J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of autophagic cell death of glioma-initiating cells by cell-penetrating D-isomer peptides consisting of Pas and the p53 C-terminus.
    Ueda Y; Wei FY; Hide T; Michiue H; Takayama K; Kaitsuka T; Nakamura H; Makino K; Kuratsu J; Futaki S; Tomizawa K
    Biomaterials; 2012 Dec; 33(35):9061-9. PubMed ID: 23006589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.
    Zhuang W; Long L; Zheng B; Ji W; Yang N; Zhang Q; Liang Z
    Cancer Sci; 2012 Apr; 103(4):684-90. PubMed ID: 22192169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy.
    Zhuang W; Li B; Long L; Chen L; Huang Q; Liang ZQ
    Brain Res; 2011 Jan; 1371():7-15. PubMed ID: 21108935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia.
    Randriarimanana T; Chateau A; Faivre B; Pinel S; Boura C
    Life Sci; 2015 Sep; 137():74-80. PubMed ID: 26239438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.
    Han S; Shin H; Lee JK; Liu Z; Rabadan R; Lee J; Shin J; Lee C; Yang H; Kim D; Kim SH; Kim J; Oh JW; Kong DS; Lee JI; Seol HJ; Choi JW; Kang HJ; Nam DH
    Exp Mol Med; 2019 Dec; 51(12):1-11. PubMed ID: 31811117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.